These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 30721406)

  • 1. Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation.
    Sekiya H; Kowa H; Koga H; Takata M; Satake W; Futamura N; Funakawa I; Jinnai K; Takahashi M; Kondo T; Ueno Y; Kanagawa M; Kobayashi K; Toda T
    Acta Neuropathol; 2019 Mar; 137(3):455-466. PubMed ID: 30721406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions.
    Kaji S; Maki T; Ishimoto T; Yamakado H; Takahashi R
    Transl Neurodegener; 2020; 9():7. PubMed ID: 32095235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-Based Evaluation of α-Synuclein Pathology in Multiple System Atrophy as a Novel Tool to Recognize Disease Subtypes.
    Kim A; Yoshida K; Kovacs GG; Forrest SL
    Mod Pathol; 2024 Aug; 37(8):100533. PubMed ID: 38852813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robust α-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophy.
    Hass EW; Sorrentino ZA; Lloyd GM; McFarland NR; Prokop S; Giasson BI
    Acta Neuropathol Commun; 2021 May; 9(1):80. PubMed ID: 33941284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular pathology in multiple system atrophy.
    Wakabayashi K; Takahashi H
    Neuropathology; 2006 Aug; 26(4):338-45. PubMed ID: 16961071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions.
    Koga S; Lin WL; Walton RL; Ross OA; Dickson DW
    Neuropathol Appl Neurobiol; 2018 Dec; 44(7):707-721. PubMed ID: 29660838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOBP and HIP1 in multiple system atrophy: New α-synuclein partners in glial cytoplasmic inclusions implicated in the disease pathogenesis.
    Bettencourt C; Miki Y; Piras IS; de Silva R; Foti SC; Talboom JS; Revesz T; Lashley T; Balazs R; Viré E; Warner TT; Huentelman MJ; Holton JL
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):640-652. PubMed ID: 33368549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates.
    Yamaguchi H; Nishimura Y; Matsuse D; Sekiya H; Masaki K; Tanaka T; Saiga T; Harada M; Kira YI; Dickson DW; Fujishima K; Matsuo E; Tanaka KF; Yamasaki R; Isobe N; Kira JI
    Brain Behav Immun; 2024 Oct; 121():122-141. PubMed ID: 38986725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.
    Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM
    Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple system atrophy: alpha-synuclein and neuronal degeneration.
    Yoshida M
    Neuropathology; 2007 Oct; 27(5):484-93. PubMed ID: 18018485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal change multiple system atrophy: an aggressive variant?
    Ling H; Asi YT; Petrovic IN; Ahmed Z; Prashanth LK; Hazrati LN; Nishizawa M; Ozawa T; Lang A; Lees AJ; Revesz T; Holton JL
    Mov Disord; 2015 Jun; 30(7):960-7. PubMed ID: 25854893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abundant glial alpha-synuclein pathology in a case without overt clinical symptoms.
    Parkkinen L; Hartikainen P; Alafuzoff I
    Clin Neuropathol; 2007; 26(6):276-83. PubMed ID: 18232593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein immunoreactivity and ultrastructural study of glial cytoplasmic inclusions in multiple system atrophy.
    Wang Y; Lü C; Ye Z
    Chin Med J (Engl); 2002 Oct; 115(10):1491-5. PubMed ID: 12490094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological substrate of memory impairment in multiple system atrophy.
    Miki Y; Tanji K; Shinnai K; Tanaka MT; Altay F; Foti SC; Strand C; Sasaki T; Kon T; Shimoyama S; Furukawa T; Nishijima H; Yamazaki H; Asi YT; Bettencourt C; Jaunmuktane Z; Tada M; Mori F; Mizukami H; Tomiyama M; Lashuel HA; Lashley T; Kakita A; Ling H; Lees AJ; Holton JL; Warner TT; Wakabayashi K
    Neuropathol Appl Neurobiol; 2022 Dec; 48(7):e12844. PubMed ID: 35906771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of Hsc70 and Hsp70 in glial cytoplasmic inclusions in patients with multiple system atrophy.
    Kawamoto Y; Akiguchi I; Shirakashi Y; Honjo Y; Tomimoto H; Takahashi R; Budka H
    Brain Res; 2007 Mar; 1136(1):219-27. PubMed ID: 17240362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human alpha-synuclein overexpressing MBP29 mice mimic functional and structural hallmarks of the cerebellar subtype of multiple system atrophy.
    Mészáros L; Riemenschneider MJ; Gassner H; Marxreiter F; von Hörsten S; Hoffmann A; Winkler J
    Acta Neuropathol Commun; 2021 Apr; 9(1):68. PubMed ID: 33853667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-localization of alpha-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration.
    Piao YS; Hayashi S; Hasegawa M; Wakabayashi K; Yamada M; Yoshimoto M; Ishikawa A; Iwatsubo T; Takahashi H
    Acta Neuropathol; 2001 Mar; 101(3):285-93. PubMed ID: 11307630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy.
    Koga S; Dickson DW
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):175-184. PubMed ID: 28860330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNCA and TPPP transcripts increase in oligodendroglial cytoplasmic inclusions in multiple system atrophy.
    Kon T; Forrest SL; Lee S; Li J; Chasiotis H; Nassir N; Uddin MJ; Lang AE; Kovacs GG
    Neurobiol Dis; 2024 Aug; 198():106551. PubMed ID: 38839023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes.
    Armstrong RA; Cairns NJ; Lantos PL
    Parkinsonism Relat Disord; 2006 Sep; 12(6):356-62. PubMed ID: 16723266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.